Establishment Labs
ESTA
Market cap $1.18B

42.29 USD

-0.62

1.44%

At close Oct 17, 4:00 PM EDT

After hours

42.29

+0.00

0.00%

1 day

-1.44%

5 days

9.76%

1 month

-2.92%

3 months

-11.01%

6 months

-18.91%

Year to date

59.04%

1 year

5.65%

5 years

124.47%

About: Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Employees: 857

Healthcare Orthopedic, Prosthetic & Surgical Appliances & Supplies

0

Funds holding %

of 6,740 funds

0

Analysts bullish %

of 5 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

29% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 21

21% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 34

8.41% more ownership

Funds ownership: 87.0% [Q1] → 95.41% (+8.41%) [Q2]

5% more funds holding

Funds holding: 116 [Q1] → 122 (+6) [Q2]

1% less capital invested

Capital invested by funds: $1.2B [Q1] → $1.19B (-$12M) [Q2]

10% less call options, than puts

Call options by funds: $6.85M | Put options by funds: $7.58M

14% less funds holding in top 10

Funds holding in top 10: 7 [Q1] → 6 (-1) [Q2]

See Fund Rankings

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$45

6%

upside

Avg. target

$56

31%

upside

High target

$68

61%

upside

5 analyst ratings

3 positive

60%

2 neutral

40%

0 negative

0%

BTIG Marie Thibault 73% 1-year accuracy 8 / 11 met price target	54%upside $65	Buy Maintained	14 Oct 2024
Citigroup Joanne Wuensch 69% 1-year accuracy 25 / 36 met price target	18%upside $50	Neutral Maintained	1 Oct 2024
Citigroup Joanne Wuensch 69% 1-year accuracy 25 / 36 met price target	6%upside $45	Neutral Maintained	22 Aug 2024
Stephens & Co. George Sellers 21% 1-year accuracy 3 / 14 met price target	61%upside $68	Overweight Reiterated	7 Aug 2024
JP Morgan Allen Gong 56% 1-year accuracy 5 / 9 met price target	18%upside $50	Overweight Maintained	7 Aug 2024

See Analyst Rankings

Financial journalist opinion

Based on 4 articles about ESTA published over the past 30 days

Establishment Labs Publishes 2024 Post Market Surveillance Report

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced that it has published its 2024 Post Market Surveillance (PMS) Report. “It is fitting that as we publish our 2024 PMS report, we begin broadly shipping across the United States,” said Juan José Chacón-Quirós, Establishment Labs CEO and Founder. “Dozens of plastic surgeons.

Establishment Labs Publishes 2024 Post Market Surveillance Report

Establishment Labs Holdings Inc (ESTA) Stock Price Up 9.25% on Oct 2

Shares of Establishment Labs Holdings Inc (ESTA, Financial) surged 9.25% in mid-day trading on Oct 2. The stock reached an intraday high of $44.42, before settling at $44.31, up from its previous close of $40.56.

Establishment Labs Holdings Inc (ESTA) Stock Price Up 9.25% on Oct 2

First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced today that the first patients in the United States have successfully undergone breast augmentation with Motiva® Implants. “With the FDA approval last week, we are experiencing high demand for Motiva Implants — both from surgeons and patients,” said Juan José Chacón-Quirós.

First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants

Establishment Labs Receives U.S. FDA Approval for Motiva Implants

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round breast implants in primary and revision breast augmentation. “Today's approval is transformative for breast aesthetics in.

Establishment Labs Receives U.S. FDA Approval for Motiva Implants

Zacks Investment Research

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.65 per share a year ago.

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

Establishment Labs Reports Second Quarter 2024 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the second quarter ended June 30, 2024. Second Quarter Highlights and Outlook Second quarter worldwide revenue of $44.1 million. 2024 revenue guidance remains $174 million to $184 million, an increase of 5% to 11% over 2023. Gross profit for th.

Establishment Labs Reports Second Quarter 2024 Financial Results

Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2024, after the market closes on Tuesday, August 6, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results. To participate in the conference call, dial (800) 715-9871 (U.S. and Can.

Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6

Zacks Investment Research

Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?

Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?

Establishment Labs Announces Participation in Two Upcoming Investment Conferences

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences. Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Chief Financial Officer, will participate in the 2024 Jefferies Global Healthcare Conference being held June 5-6, 2024. Mr. Chacón.

Establishment Labs Announces Participation in Two Upcoming Investment Conferences

Establishment Labs Holdings Inc. (ESTA) Q1 2024 Earnings Call Transcript

Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Raj Denhoy - Chief Financial Officer Juan Jose Chacon Quiros - Chief Executive Officer Conference Call Participants Harrison Parsons - Stephens Inc. Allen Gong - JPMorgan Marie Thibault - BTIG Anthony Petrone - Mizuho Securities Matt Taylor - Jefferies Joanne Wuensch - Citibank Josh Jennings - TD Cowen Operator Good afternoon. Welcome to Establishment Labs First Quarter 2024 Earnings Call.

Establishment Labs Holdings Inc. (ESTA) Q1 2024 Earnings Call Transcript

See News Rankings

Charts implemented using Lightweight Charts™